• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白酶激活受体 2 在炎症性皮肤病中的作用:现有证据和未来展望。

Protease-Activated Receptor 2 in inflammatory skin disease: current evidence and future perspectives.

机构信息

Department of Dermatology, Huashan Hosptial, Fudan University, Shanghai, China.

iHuman Institute, ShanghaiTech University, Shanghai, China.

出版信息

Front Immunol. 2024 Sep 5;15:1448952. doi: 10.3389/fimmu.2024.1448952. eCollection 2024.

DOI:10.3389/fimmu.2024.1448952
PMID:39301020
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11410643/
Abstract

Protease-activated receptor-2 (PAR2) is a class-A G protein-coupled receptor (GPCR) activated by serine proteases and is expressed by multiple tissues, including the skin. PAR2 is involved in the skin inflammatory response, promoting Th2 inflammation, delaying skin barrier repair, and affecting the differentiation of keratinocytes. It also participates in the transmission of itch and pain sensations in the skin. Increasing evidence indicates that PAR2 plays an important role in the pathogenesis of inflammatory skin diseases such as acne vulgaris, rosacea, psoriasis, and atopic dermatitis. Additional focus will be placed on potential targeted therapies based on PAR2. The Goal of this review is to outline the emerging effects of PAR2 activation in inflammatory skin disease and highlight the promise of PAR2 modulators.

摘要

蛋白酶激活受体 2(PAR2)是一种 A 类 G 蛋白偶联受体(GPCR),可被丝氨酸蛋白酶激活,表达于多种组织,包括皮肤。PAR2 参与皮肤炎症反应,促进 Th2 炎症,延迟皮肤屏障修复,并影响角质形成细胞的分化。它还参与皮肤瘙痒和疼痛感觉的传递。越来越多的证据表明,PAR2 在痤疮、酒渣鼻、银屑病和特应性皮炎等炎症性皮肤病的发病机制中起重要作用。研究重点还将放在基于 PAR2 的潜在靶向治疗上。本文旨在概述 PAR2 激活在炎症性皮肤病中的新作用,并强调 PAR2 调节剂的应用前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deec/11410643/dda86a93c290/fimmu-15-1448952-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deec/11410643/088f3a209165/fimmu-15-1448952-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deec/11410643/633a401cd113/fimmu-15-1448952-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deec/11410643/dda86a93c290/fimmu-15-1448952-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deec/11410643/088f3a209165/fimmu-15-1448952-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deec/11410643/633a401cd113/fimmu-15-1448952-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deec/11410643/dda86a93c290/fimmu-15-1448952-g003.jpg

相似文献

1
Protease-Activated Receptor 2 in inflammatory skin disease: current evidence and future perspectives.蛋白酶激活受体 2 在炎症性皮肤病中的作用:现有证据和未来展望。
Front Immunol. 2024 Sep 5;15:1448952. doi: 10.3389/fimmu.2024.1448952. eCollection 2024.
2
Update on protease-activated receptor 2 in inflammatory and autoimmune dermatological diseases.蛋白酶激活受体 2 在炎症性和自身免疫性皮肤病中的研究进展。
Front Immunol. 2024 Sep 19;15:1449126. doi: 10.3389/fimmu.2024.1449126. eCollection 2024.
3
Protease-Activated Receptor-2 Regulates Neuro-Epidermal Communication in Atopic Dermatitis.蛋白酶激活受体 2 调控特应性皮炎的神经表皮通讯。
Front Immunol. 2020 Aug 12;11:1740. doi: 10.3389/fimmu.2020.01740. eCollection 2020.
4
PAR2 Mediates Itch via TRPV3 Signaling in Keratinocytes.PAR2 通过角质形成细胞中的 TRPV3 信号转导介导瘙痒。
J Invest Dermatol. 2020 Aug;140(8):1524-1532. doi: 10.1016/j.jid.2020.01.012. Epub 2020 Jan 29.
5
The role of PAR2 in regulating MIF release in house dust mite-induced atopic dermatitis.蛋白酶激活受体 2 在屋尘螨诱导的特应性皮炎中调节巨噬细胞移动抑制因子释放的作用。
Front Immunol. 2024 Oct 2;15:1478292. doi: 10.3389/fimmu.2024.1478292. eCollection 2024.
6
Update on protease-activated receptor 2 in cutaneous barrier, differentiation, tumorigenesis and pigmentation, and its role in related dermatologic diseases.蛋白酶激活受体 2 在皮肤屏障、分化、肿瘤发生和色素沉着中的最新研究进展,及其在相关皮肤科疾病中的作用。
Exp Dermatol. 2019 Aug;28(8):877-885. doi: 10.1111/exd.13936. Epub 2019 May 15.
7
Neuronal BST2: A Pruritic Mediator alongside Protease-Activated Receptor 2 in the IL-27-Driven Itch Pathway.神经元 BST2:IL-27 驱动的瘙痒通路中与蛋白酶激活受体 2 一起的瘙痒介质。
J Invest Dermatol. 2024 Aug;144(8):1829-1842.e4. doi: 10.1016/j.jid.2024.01.025. Epub 2024 Feb 13.
8
Agonists of proteinase-activated receptor-2 stimulate upregulation of intercellular cell adhesion molecule-1 in primary human keratinocytes via activation of NF-kappa B.蛋白酶激活受体-2激动剂通过激活核因子κB刺激原代人角质形成细胞中细胞间黏附分子-1的上调。
J Invest Dermatol. 2005 Jan;124(1):38-45. doi: 10.1111/j.0022-202X.2004.23539.x.
9
Persistent kallikrein 5 activation induces atopic dermatitis-like skin architecture independent of PAR2 activity.持续的激肽释放酶 5 激活可诱导特应性皮炎样皮肤结构,而不依赖于 PAR2 活性。
J Allergy Clin Immunol. 2017 Nov;140(5):1310-1322.e5. doi: 10.1016/j.jaci.2017.01.025. Epub 2017 Feb 24.
10
Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis.蛋白酶和蛋白酶激活受体-2 在特应性皮炎发病机制中的作用。
Yonsei Med J. 2010 Nov;51(6):808-22. doi: 10.3349/ymj.2010.51.6.808.

引用本文的文献

1
Host-Microbiome Interactions in Chronic Itch.慢性瘙痒中的宿主-微生物组相互作用
J Clin Med. 2025 Aug 9;14(16):5633. doi: 10.3390/jcm14165633.
2
A New Strategy in Modulating the Protease-Activated Receptor 2 (Par2) in Autoimmune Diseases.一种调节自身免疫性疾病中蛋白酶激活受体2(Par2)的新策略。
Int J Mol Sci. 2025 Jan 6;26(1):410. doi: 10.3390/ijms26010410.

本文引用的文献

1
Neuronal BST2: A Pruritic Mediator alongside Protease-Activated Receptor 2 in the IL-27-Driven Itch Pathway.神经元 BST2:IL-27 驱动的瘙痒通路中与蛋白酶激活受体 2 一起的瘙痒介质。
J Invest Dermatol. 2024 Aug;144(8):1829-1842.e4. doi: 10.1016/j.jid.2024.01.025. Epub 2024 Feb 13.
2
Blockade of Proteinase-Activated Receptor 2 (PAR2) Attenuates Neuroinflammation in Experimental Autoimmune Encephalomyelitis.蛋白酶激活受体 2(PAR2)阻断减轻实验性自身免疫性脑脊髓炎的神经炎症。
J Pharmacol Exp Ther. 2024 Jan 2;388(1):12-22. doi: 10.1124/jpet.123.001685.
3
Protease-Activated Receptor-2 and Phospholipid Metabolism Analysis in Hyperuricemia-Induced Renal Injury.
高尿酸血症诱导肾损伤中蛋白酶激活受体-2 与磷脂代谢分析。
Mediators Inflamm. 2023 Jul 13;2023:5007488. doi: 10.1155/2023/5007488. eCollection 2023.
4
FSLLRY-NH, a protease-activated receptor 2 (PAR2) antagonist, activates mas-related G protein-coupled receptor C11 (MrgprC11) to induce scratching behaviors in mice.FSLLRY-NH,一种蛋白酶激活受体 2(PAR2)拮抗剂,可激活与 Mas 相关的 G 蛋白偶联受体 C11(MrgprC11),从而诱导小鼠搔抓行为。
Life Sci. 2023 Jul 15;325:121786. doi: 10.1016/j.lfs.2023.121786. Epub 2023 May 16.
5
C781, a β-Arrestin Biased Antagonist at Protease-Activated Receptor-2 (PAR2), Displays in vivo Efficacy Against Protease-Induced Pain in Mice.C781,一种蛋白酶激活受体 2(PAR2)的β-arrestin 偏向性拮抗剂,在体内对蛋白酶诱导的疼痛具有治疗作用。
J Pain. 2023 Apr;24(4):605-616. doi: 10.1016/j.jpain.2022.11.006. Epub 2022 Nov 20.
6
GB83, an Agonist of PAR2 with a Unique Mechanism of Action Distinct from Trypsin and PAR2-AP.GB83,一种作用机制独特的 PAR2 激动剂,与胰蛋白酶和 PAR2-AP 不同。
Int J Mol Sci. 2022 Sep 13;23(18):10631. doi: 10.3390/ijms231810631.
7
β-Arrestin-biased proteinase-activated receptor-2 antagonist C781 limits allergen-induced airway hyperresponsiveness and inflammation.β-抑制蛋白偶联受体 2 拮抗剂 C781 可抑制变应原诱导的气道高反应性和炎症。
Br J Pharmacol. 2023 Mar;180(5):667-680. doi: 10.1111/bph.15903. Epub 2022 Dec 5.
8
The Yin-Yang roles of protease-activated receptors in inflammatory signalling and diseases.蛋白酶激活受体在炎症信号转导和疾病中的阴阳作用。
FEBS J. 2022 Jul;289(14):4000-4020. doi: 10.1111/febs.16406. Epub 2022 Mar 3.
9
Blockade of protease-activated receptor 2 attenuates allergenmediated acute lung inflammation and leukocyte recruitment in mice.蛋白酶激活受体 2 阻断剂可减轻变应原介导的小鼠急性肺炎症和白细胞募集。
J Biosci. 2022;47.
10
Proteinase-activated receptor-2 antagonist C391 inhibits Alternaria-induced airway epithelial signalling and asthma indicators in acute exposure mouse models.蛋白酶激活受体-2 拮抗剂 C391 抑制急性暴露小鼠模型中交链格孢菌诱导的气道上皮信号和哮喘指标。
Br J Pharmacol. 2022 May;179(10):2208-2222. doi: 10.1111/bph.15745. Epub 2022 Feb 1.